153 related articles for article (PubMed ID: 17507865)
21. Circulating CD4+CD25 high regulatory T cells and natural killer T cells in children with newly diagnosed type 1 diabetes or with diabetes-associated autoantibodies.
Oling V; Marttila J; Knip M; Simell O; Ilonen J
Ann N Y Acad Sci; 2007 Jun; 1107():363-72. PubMed ID: 17804564
[TBL] [Abstract][Full Text] [Related]
22. Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus.
Barath S; Aleksza M; Tarr T; Sipka S; Szegedi G; Kiss E
Lupus; 2007; 16(7):489-96. PubMed ID: 17670847
[TBL] [Abstract][Full Text] [Related]
23. [The role of regulatory T-cells in autoimmune rheumatic diseases].
Nasonov EL; Bykovskaia SN
Vestn Ross Akad Med Nauk; 2006; (9-10):74-82. PubMed ID: 17111929
[TBL] [Abstract][Full Text] [Related]
24. Unmasking of autoreactive CD4 T cells by depletion of CD25 regulatory T cells in systemic lupus erythematosus.
Engler JB; Undeutsch R; Kloke L; Rosenberger S; Backhaus M; Schneider U; Egerer K; Dragun D; Hofmann J; Huscher D; Burmester GR; Humrich JY; Enghard P; Riemekasten G
Ann Rheum Dis; 2011 Dec; 70(12):2176-83. PubMed ID: 21926188
[TBL] [Abstract][Full Text] [Related]
25. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
26. The different effects of indirubin on effector and CD4+CD25+ regulatory T cells in mice: potential implication for the treatment of autoimmune diseases.
Zhang A; Qu Y; Zhang B; Zhang L; Zeng C; Peng J; Ji X; Hou M; Zhao Y
J Mol Med (Berl); 2007 Nov; 85(11):1263-70. PubMed ID: 17639287
[TBL] [Abstract][Full Text] [Related]
27. Activated T cells complicate the identification of regulatory T cells in rheumatoid arthritis.
Aerts NE; Dombrecht EJ; Ebo DG; Bridts CH; Stevens WJ; De Clerck LS
Cell Immunol; 2008 Feb; 251(2):109-15. PubMed ID: 18538752
[TBL] [Abstract][Full Text] [Related]
28. Role of new population of peripheral CD11c(+)CD8(+) T cells and CD4(+)CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients.
Kao JK; Hsue YT; Lin CY
J Microbiol Immunol Infect; 2007 Oct; 40(5):419-27. PubMed ID: 17932602
[TBL] [Abstract][Full Text] [Related]
29. Activation antigens expressed on T-cells of the peripheral blood in Sjögren's syndrome and rheumatoid arthritis.
Ichikawa Y; Shimizu H; Yoshida M; Arimori S
Clin Exp Rheumatol; 1990; 8(3):243-9. PubMed ID: 1974181
[TBL] [Abstract][Full Text] [Related]
30. Conserved anti-proliferative effect and poor inhibition of TNFalpha secretion by regulatory CD4+CD25+ T cells in patients with systemic lupus erythematosus.
Gómez J; Prado C; López P; Suárez A; Gutiérrez C
Clin Immunol; 2009 Sep; 132(3):385-92. PubMed ID: 19540813
[TBL] [Abstract][Full Text] [Related]
31. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
32. CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo.
Siepmann K; Biester S; Plsková J; Muckersie E; Duncan L; Forrester JV
Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):221-9. PubMed ID: 16741709
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
[TBL] [Abstract][Full Text] [Related]
34. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome.
Gottenberg JE; Lavie F; Abbed K; Gasnault J; Le Nevot E; Delfraissy JF; Taoufik Y; Mariette X
J Autoimmun; 2005 May; 24(3):235-42. PubMed ID: 15848046
[TBL] [Abstract][Full Text] [Related]
35. Toll-like receptor 2-mediated modulation of growth and functions of regulatory T cells by oral streptococci.
Saeki A; Segawa T; Abe T; Sugiyama M; Arimoto T; Hara H; Hasebe A; Ohtani M; Tanizume N; Ohuchi M; Kataoka H; Kawanami M; Yokoyama A; Shibata K
Mol Oral Microbiol; 2013 Aug; 28(4):267-80. PubMed ID: 23413817
[TBL] [Abstract][Full Text] [Related]
36. The immunoregulatory role of CD4⁺ FoxP3⁺ CD25⁻ regulatory T cells in lungs of mice infected with Bordetella pertussis.
Coleman MM; Finlay CM; Moran B; Keane J; Dunne PJ; Mills KH
FEMS Immunol Med Microbiol; 2012 Apr; 64(3):413-24. PubMed ID: 22211712
[TBL] [Abstract][Full Text] [Related]
37. [Regulatory T cells in systemic lupus erythematosus].
Okamura T; Morita K; Fujio K; Yamamoto K
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):69-77. PubMed ID: 25765691
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.
Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE
Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases.
Wahl SM; Chen W
Arthritis Res Ther; 2005; 7(2):62-8. PubMed ID: 15743491
[TBL] [Abstract][Full Text] [Related]
40. [Altered frequency of CD4+CD25-Foxp3+ T cells in patients with systemic lupus erythematosus].
Yan B; Liu Y; Xie QB; Liu G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):695-8. PubMed ID: 19664391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
